reports
Merck Kgaa: 2 directors
Two Directors at Merck Kgaa bought 7,768 shares at 159.245EUR. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
- Ana Arjona-Martinez
- Antonio Rodriguez Vicens
- Ana Arjona-Martinez
- Antonio Rodriguez Vicens
- Benoit Valleaux
- Roland Pfaender
- MBA
- CFA
- CCRA
Talanx AG : Strong FY 2023 results allowed for building additional red...
>We increase estimates following strong FY 2023 results reporting - Talanx reported a strong set of FY 2023 results in line with preliminary results reporting. Group net profit came to € 1,581m, up 124% y-o-y. Underlying results were even stronger as the group built up reserve redundancies and realised losses on fixed income instruments to generate a higher ordinary investment income in future years. We have increased our estimates for Talanx driven by higher estimat...
- Salome Charamalet
- Stefano Toffano
ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 03/07/2024
We are initiating coverage of Lonza with a target price of CHF 535 and an Outperform rating. As one of the world's leading contract development and manufacturing organisations (CDMO), Lonza is predestined to benefit from the sustainable drivers of this industry. The group's global presence and strong market positions in the growth areas of biologics and cell and gene therapy (CGT) will fuel double-digit sales growth and >30% EBITDA margins in the medium term. Despite significant growt...
LHA DEUTSCHE LUFTHANSA AG
JMT JERONIMO MARTINS SGPS S.A.
G1A GEA GROUP AG
RCO REMY COINTREAU SA
SCR SCOR SE
TEP TELEPERFORMANCE SE
RF EURAZEO SA
MRK MERCK KGAA
BAYN BAYER AG
TIT TELECOM ITALIA S.P.A.
BNR BRENNTAG SE
PIRC PIRELLI & C. S.P.A.
NEXI NEXI S.P.A.
AZE AZELIS GROUP NV
- Salome Charamalet
- Stefano Toffano
ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 07/03/2024
We are initiating coverage of Lonza with a target price of CHF 535 and an Outperform rating. As one of the world's leading contract development and manufacturing organisations (CDMO), Lonza is predestined to benefit from the sustainable drivers of this industry. The group's global presence and strong market positions in the growth areas of biologics and cell and gene therapy (CGT) will fuel double-digit sales growth and >30% EBITDA margins in the medium term. Despite significant growt...
LHA DEUTSCHE LUFTHANSA AG
JMT JERONIMO MARTINS SGPS S.A.
G1A GEA GROUP AG
RCO REMY COINTREAU SA
SCR SCOR SE
TEP TELEPERFORMANCE SE
RF EURAZEO SA
MRK MERCK KGAA
BAYN BAYER AG
TIT TELECOM ITALIA S.P.A.
BNR BRENNTAG SE
PIRC PIRELLI & C. S.P.A.
NEXI NEXI S.P.A.
AZE AZELIS GROUP NV
- Oliver Metzger
Merck KGaA : FY review -Outlook better on healthcare, but more cautiou...
>Q4 review – Slight beat in Q4 - Q4 2023 revenues of € 5,225m (-7.7% y-o-y) were 0%/+2% vs ODDO BHF/consensus. The organic decline was -2.9%, (ODDO BHF -3.8%). EBITDA pre of € 1,293m (-19.8% y-o-y, margin 24.7%) was 5%/1% better than ODDO BH/consensus. Core EPS was € 1.85 some 0%/3% ahead of expectations on a lower tax rate. For 2024, the company expects slight to modest organic growth with a forex headwind of 0% to -3% (ODDO BHF 4.9% organic growth, consensus 1.8% in...
- Anthony Dick
- Michael Foundoukidis
ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 02/02/2024
Sodexo boasts a defensive profile and significant potential for operational improvement, with progress increasingly visible since Sophie Bellon’s arrival as CEO. These factors are set to endure, narrowing the gap with Compass, and its transformation into a catering pure player following Pluxee’s spin-off in early 2024 should facilitate the group’s rerating. Outperform rating reiterated and a target price € 98 following Pluxee’s spin-off (combined Sodexo + Pluxee target price of € 12...
- Anthony Dick
- Michael Foundoukidis
ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 02/02/2024
Sodexo bénéficie d’un profil défensif et d’un fort potentiel d’amélioration opérationnelle, avec des progrès de plus en plus visibles depuis l’arrivée de Sophie Bellon comme CEO. Ceux-ci devraient se poursuivre, réduisant l’écart avec Compass, et sa transformation en un pure player, à la suite du spin-off de Pluxee début 2024, devrait faciliter son rerating boursier. Surperformance réitérée et OC à 98 € à la suite du spin-off de Pluxee (OC combinés Sodexo + Pluxee à 129 € vs OC de 118...
- Oliver Metzger
Merck KGaA : Factor in Life Sciences with slower finish, Electronics w...
>Q4 preview – Ongoing weak momentum - Q4 revenues of € 5,131m (-9.3% y-o-y) should be impacted by an organic decline of -3.8% and forex headwind of 550bp. Within the divisions, we see the strongest decline coming from Life Sciences with an organic decline of 12.1% on the back of ongoing destocking. We forecast Electronics to decline by 4.3% organically on the back of a weak semiconductor market. On the other hand, Healthcare is expected to grow with a strong 7.0% in t...
- Olfa Taamallah
- Yan Derocles
- Olfa Taamallah
- Yan Derocles
- Oliver Metzger
Merck KGaA : Failure of evobrutinib
>Phase III failed - The company announced that its phase III study for evobrutinib has not meet its primary endpoint of reducing the annualised relapse rates (ARR) in multiple sclerosis (MS) compared to oral teriflunomide. While the ARR of evobrutinib showed an ongoing unchanged level in phase III compared to previous phases, teriflunomide showed better efficacy than in other phase III studies. Consequently, we believe that the design of the phase III study had some p...
- Emmanuel Matot
PUB PUBLICIS GROUPE SA
DGE DIAGEO PLC
RNO RENAULT SA
AGN AEGON NV
ALO ALSTOM SA
TLX TALANX AG
WPP WPP PLC
SOI SOITEC SA
EVK EVONIK INDUSTRIES AG
SIE SIEMENS AG
SHL SIEMENS HEALTHINEERS AG
EVD CTS EVENTIM AG & CO. KGAA
HFG HELLOFRESH SE
ALG ALLEGRO.EU SA
ENR SIEMENS ENERGY AG
SHUR SHURGARD SELF STORAGE LIMITED
- Emmanuel Matot
DGE DIAGEO PLC
RNO RENAULT SA
AGN AEGON NV
ALO ALSTOM SA
TLX TALANX AG
SOI SOITEC SA
EVK EVONIK INDUSTRIES AG
SIE SIEMENS AG
SHL SIEMENS HEALTHINEERS AG
EVD CTS EVENTIM AG & CO. KGAA
HFG HELLOFRESH SE
ALG ALLEGRO.EU SA
ENR SIEMENS ENERGY AG
SHUR SHURGARD SELF STORAGE LIMITED
- Benoit Valleaux
- Roland Pfaender
- MBA
- CFA
- CCRA
Talanx AG : Improving underlying technical results in Q3 2023
>Strong Q3 2023 supports higher estimates going forward - Talanx reported a healthy set of Q3 2023 results. Reported quarterly net profit came to € 452m and was thus comfortably in line with the pre-released guidance of >€ 423m and our earlier estimate of € 329m, helped by a strong performance of most primary insurance operations and a very low tax rate of 12.1% in the period. Reported EBIT of € 802m undershot our estimate of € 854m triggered by a lower-than-expected...
- Julian Dobrovolschi
AKE ARKEMA
CON CONTINENTAL AKTIENGESELLSCHAFT
LHN LAFARGEHOLCIM LTD.
LR LEGRAND SA
ENX EURONEXT NV
VIE VEOLIA ENVIRONNEMENT SA
O2D TELEFONICA DEUTSCHLAND HOLDING AG
PROX PROXIMUS SA DE DROIT PUBLIC
MT ARCELORMITTAL SA
KPN ROYAL KPN NV
ORA ORANGE SA
CBK COMMERZBANK AG
NOVN NOVARTIS AG
FGR EIFFAGE SA
EN BOUYGUES SA
MUV2 MUNICH REINSURANCE COMPANY
UTDI UNITED INTERNET AG
RHM RHEINMETALL AG
KBC KBC GROUP N.V.
TNET TELENET GROUP HOLDING NV
GAMA GAMMA COMMUNICATIONS
MRK MERCK KGAA
EOAN E.ON SE
G ASSICURAZIONI GENERALI S.P.A.
AIR AIRBUS SE
HEN3 HENKEL AG & CO. KGAA PREF
DTE DEUTSCHE TELEKOM AG
LEG LEG IMMOBILIEN AG
KGX KION GROUP AG
TIT TELECOM ITALIA S.P.A.
BNR BRENNTAG SE
COLO B COLOPLAST A/S CLASS B
AUTO AUTO TRADER GROUP PLC
CLNX CELLNEX TELECOM S.A.
FNTN FREENET AG
HLAG HAPAG-LLOYD AG
AZN ASTRAZENECA PLC
VOD VODAFONE GROUP PLC
OBEL ORANGE BELGIUM SA
TEF TELEFONICA SA
NFN NFON AG
DRI 1&1 DRILLISCH AG
ADYEN ADYEN NV
NEXI NEXI S.P.A.
VWS VESTAS WIND SYSTEMS
AZE AZELIS GROUP NV
DSFIR KONINKLIJKE DSM N.V.
ARM ARM HOLDINGS PLC
- Emira Sagaama
- Julian Dobrovolschi
AKE ARKEMA
CON CONTINENTAL AKTIENGESELLSCHAFT
LHN LAFARGEHOLCIM LTD.
LR LEGRAND SA
ENX EURONEXT NV
VIE VEOLIA ENVIRONNEMENT SA
O2D TELEFONICA DEUTSCHLAND HOLDING AG
PROX PROXIMUS SA DE DROIT PUBLIC
MT ARCELORMITTAL SA
KPN ROYAL KPN NV
ORA ORANGE SA
CBK COMMERZBANK AG
NOVN NOVARTIS AG
FGR EIFFAGE SA
EN BOUYGUES SA
MUV2 MUNICH REINSURANCE COMPANY
UTDI UNITED INTERNET AG
RHM RHEINMETALL AG
KBC KBC GROUP N.V.
TNET TELENET GROUP HOLDING NV
GAMA GAMMA COMMUNICATIONS
MRK MERCK KGAA
EOAN E.ON SE
G ASSICURAZIONI GENERALI S.P.A.
AIR AIRBUS SE
HEN3 HENKEL AG & CO. KGAA PREF
DTE DEUTSCHE TELEKOM AG
LEG LEG IMMOBILIEN AG
KGX KION GROUP AG
TIT TELECOM ITALIA S.P.A.
BNR BRENNTAG SE
COLO B COLOPLAST A/S CLASS B
AUTO AUTO TRADER GROUP PLC
CLNX CELLNEX TELECOM S.A.
FNTN FREENET AG
HLAG HAPAG-LLOYD AG
AZN ASTRAZENECA PLC
VOD VODAFONE GROUP PLC
OBEL ORANGE BELGIUM SA
TEF TELEFONICA SA
NFN NFON AG
DRI 1&1 DRILLISCH AG
ADYEN ADYEN NV
NEXI NEXI S.P.A.
VWS VESTAS WIND SYSTEMS
AZE AZELIS GROUP NV
DSFIR KONINKLIJKE DSM N.V.
ARM ARM HOLDINGS PLC
- Oliver Metzger
Merck KGaA : Q3 2023 review – Trough in Life Sciences
>Q3 review – in line with low expectations - Q3 2023 revenues of € 5,173m (-10.9% y-o-y) were in line with ODDO BHF/consensus. Organic decline was -4.1%, (ODDO BHF -6.2%). The forex headwind was 340bp. EBITDA pre of € 1,446m (-20.1% y-o-y, margin 28.0%) was 12% better than ODDO BHF and 4% ahead of consensus estimates. Core EPS of € 2.07 was 21%/7% vs expectations on a better financial result. The company reiterates its 2023 guidance on sales of € 20.5-21.9bn (ODDO BHF...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.